Global Monoclonal Antibodies Market Research Report 2021

Publisher Name :
Date: 19-Feb-2021
No. of pages: 123
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Cancer

- Autoimmune Diseases

- Infection

- Hematological Diseases

- Others

Segment by Application

- Oncology

- Autoimmune and inflammatory diseases

- Respiratory diseases

- Ophthalmology

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- AbbVie

- Roche

- Johnson & Johnson

- Amgen

- Merck

- BMS

- Eli Lilly

- Formation Biologics

- Genmab

- GlaxoSmithKline

- Human Genome Sciences

- mmunogen

- MedImmune

- Novartis

- Pfizer

- Seattle Genetics

- Stemcentrx

- Synthon Biopharmaceuticals

- Takeda

- Teva

Global Monoclonal Antibodies Market Research Report 2021

Table of Contents
1 Monoclonal Antibodies Market Overview
1.1 Product Overview and Scope of Monoclonal Antibodies
1.2 Monoclonal Antibodies Segment by Type
1.2.1 Global Monoclonal Antibodies Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Cancer
1.2.3 Autoimmune Diseases
1.2.4 Infection
1.2.5 Hematological Diseases
1.2.6 Others
1.3 Monoclonal Antibodies Segment by Application
1.3.1 Monoclonal Antibodies Sales Comparison by Application: (2021-2027)
1.3.2 Oncology
1.3.3 Autoimmune and inflammatory diseases
1.3.4 Respiratory diseases
1.3.5 Ophthalmology
1.4 Global Monoclonal Antibodies Market Size Estimates and Forecasts
1.4.1 Global Monoclonal Antibodies Revenue 2016-2027
1.4.2 Global Monoclonal Antibodies Sales 2016-2027
1.4.3 Monoclonal Antibodies Market Size by Region: 2016 Versus 2021 Versus 2027
2 Monoclonal Antibodies Market Competition by Manufacturers
2.1 Global Monoclonal Antibodies Sales Market Share by Manufacturers (2016-2021)
2.2 Global Monoclonal Antibodies Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Monoclonal Antibodies Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Monoclonal Antibodies Manufacturing Sites, Area Served, Product Type
2.5 Monoclonal Antibodies Market Competitive Situation and Trends
2.5.1 Monoclonal Antibodies Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Monoclonal Antibodies Players Market Share by Revenue
2.5.3 Global Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Monoclonal Antibodies Retrospective Market Scenario by Region
3.1 Global Monoclonal Antibodies Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Monoclonal Antibodies Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Monoclonal Antibodies Market Facts & Figures by Country
3.3.1 North America Monoclonal Antibodies Sales by Country
3.3.2 North America Monoclonal Antibodies Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Monoclonal Antibodies Market Facts & Figures by Country
3.4.1 Europe Monoclonal Antibodies Sales by Country
3.4.2 Europe Monoclonal Antibodies Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Monoclonal Antibodies Market Facts & Figures by Region
3.5.1 Asia Pacific Monoclonal Antibodies Sales by Region
3.5.2 Asia Pacific Monoclonal Antibodies Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Monoclonal Antibodies Market Facts & Figures by Country
3.6.1 Latin America Monoclonal Antibodies Sales by Country
3.6.2 Latin America Monoclonal Antibodies Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Monoclonal Antibodies Market Facts & Figures by Country
3.7.1 Middle East and Africa Monoclonal Antibodies Sales by Country
3.7.2 Middle East and Africa Monoclonal Antibodies Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Monoclonal Antibodies Historic Market Analysis by Type
4.1 Global Monoclonal Antibodies Sales Market Share by Type (2016-2021)
4.2 Global Monoclonal Antibodies Revenue Market Share by Type (2016-2021)
4.3 Global Monoclonal Antibodies Price by Type (2016-2021)
5 Global Monoclonal Antibodies Historic Market Analysis by Application
5.1 Global Monoclonal Antibodies Sales Market Share by Application (2016-2021)
5.2 Global Monoclonal Antibodies Revenue Market Share by Application (2016-2021)
5.3 Global Monoclonal Antibodies Price by Application (2016-2021)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.1.4 AbbVie Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Roche Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Johnson & Johnson Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Amgen
6.4.1 Amgen Corporation Information
6.4.2 Amgen Description and Business Overview
6.4.3 Amgen Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Amgen Product Portfolio
6.4.5 Amgen Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Merck Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 BMS
6.6.1 BMS Corporation Information
6.6.2 BMS Description and Business Overview
6.6.3 BMS Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.6.4 BMS Product Portfolio
6.6.5 BMS Recent Developments/Updates
6.7 Eli Lilly
6.6.1 Eli Lilly Corporation Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Eli Lilly Product Portfolio
6.7.5 Eli Lilly Recent Developments/Updates
6.8 Formation Biologics
6.8.1 Formation Biologics Corporation Information
6.8.2 Formation Biologics Description and Business Overview
6.8.3 Formation Biologics Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Formation Biologics Product Portfolio
6.8.5 Formation Biologics Recent Developments/Updates
6.9 Genmab
6.9.1 Genmab Corporation Information
6.9.2 Genmab Description and Business Overview
6.9.3 Genmab Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Genmab Product Portfolio
6.9.5 Genmab Recent Developments/Updates
6.10 GlaxoSmithKline
6.10.1 GlaxoSmithKline Corporation Information
6.10.2 GlaxoSmithKline Description and Business Overview
6.10.3 GlaxoSmithKline Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.10.4 GlaxoSmithKline Product Portfolio
6.10.5 GlaxoSmithKline Recent Developments/Updates
6.11 Human Genome Sciences
6.11.1 Human Genome Sciences Corporation Information
6.11.2 Human Genome Sciences Monoclonal Antibodies Description and Business Overview
6.11.3 Human Genome Sciences Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Human Genome Sciences Product Portfolio
6.11.5 Human Genome Sciences Recent Developments/Updates
6.12 mmunogen
6.12.1 mmunogen Corporation Information
6.12.2 mmunogen Monoclonal Antibodies Description and Business Overview
6.12.3 mmunogen Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.12.4 mmunogen Product Portfolio
6.12.5 mmunogen Recent Developments/Updates
6.13 MedImmune
6.13.1 MedImmune Corporation Information
6.13.2 MedImmune Monoclonal Antibodies Description and Business Overview
6.13.3 MedImmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.13.4 MedImmune Product Portfolio
6.13.5 MedImmune Recent Developments/Updates
6.14 Novartis
6.14.1 Novartis Corporation Information
6.14.2 Novartis Monoclonal Antibodies Description and Business Overview
6.14.3 Novartis Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Novartis Product Portfolio
6.14.5 Novartis Recent Developments/Updates
6.15 Pfizer
6.15.1 Pfizer Corporation Information
6.15.2 Pfizer Monoclonal Antibodies Description and Business Overview
6.15.3 Pfizer Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Pfizer Product Portfolio
6.15.5 Pfizer Recent Developments/Updates
6.16 Seattle Genetics
6.16.1 Seattle Genetics Corporation Information
6.16.2 Seattle Genetics Monoclonal Antibodies Description and Business Overview
6.16.3 Seattle Genetics Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Seattle Genetics Product Portfolio
6.16.5 Seattle Genetics Recent Developments/Updates
6.17 Stemcentrx
6.17.1 Stemcentrx Corporation Information
6.17.2 Stemcentrx Monoclonal Antibodies Description and Business Overview
6.17.3 Stemcentrx Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Stemcentrx Product Portfolio
6.17.5 Stemcentrx Recent Developments/Updates
6.18 Synthon Biopharmaceuticals
6.18.1 Synthon Biopharmaceuticals Corporation Information
6.18.2 Synthon Biopharmaceuticals Monoclonal Antibodies Description and Business Overview
6.18.3 Synthon Biopharmaceuticals Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Synthon Biopharmaceuticals Product Portfolio
6.18.5 Synthon Biopharmaceuticals Recent Developments/Updates
6.19 Takeda
6.19.1 Takeda Corporation Information
6.19.2 Takeda Monoclonal Antibodies Description and Business Overview
6.19.3 Takeda Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Takeda Product Portfolio
6.19.5 Takeda Recent Developments/Updates
6.20 Teva
6.20.1 Teva Corporation Information
6.20.2 Teva Monoclonal Antibodies Description and Business Overview
6.20.3 Teva Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Teva Product Portfolio
6.20.5 Teva Recent Developments/Updates
7 Monoclonal Antibodies Manufacturing Cost Analysis
7.1 Monoclonal Antibodies Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Monoclonal Antibodies
7.4 Monoclonal Antibodies Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Monoclonal Antibodies Distributors List
8.3 Monoclonal Antibodies Customers
9 Monoclonal Antibodies Market Dynamics
9.1 Monoclonal Antibodies Industry Trends
9.2 Monoclonal Antibodies Growth Drivers
9.3 Monoclonal Antibodies Market Challenges
9.4 Monoclonal Antibodies Market Restraints
10 Global Market Forecast
10.1 Monoclonal Antibodies Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Monoclonal Antibodies by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Monoclonal Antibodies by Type (2022-2027)
10.2 Monoclonal Antibodies Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Monoclonal Antibodies by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Monoclonal Antibodies by Application (2022-2027)
10.3 Monoclonal Antibodies Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Monoclonal Antibodies by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Monoclonal Antibodies by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Monoclonal Antibodies Sales (Kg) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Monoclonal Antibodies Sales (Kg) Comparison by Application (2021-2027)
Table 3. Global Monoclonal Antibodies Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Monoclonal Antibodies Covered in This Study
Table 5. Global Monoclonal Antibodies Sales (Kg) of Key Manufacturers (2016-2021)
Table 6. Global Monoclonal Antibodies Sales Share by Manufacturers (2016-2021)
Table 7. Global Monoclonal Antibodies Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Monoclonal Antibodies Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Monoclonal Antibodies Average Price (USD/Kg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Monoclonal Antibodies Manufacturing Sites and Area Served
Table 11. Manufacturers Monoclonal Antibodies Product Type
Table 12. Global Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Monoclonal Antibodies by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibodies as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Monoclonal Antibodies Sales by Region (2016-2021) & (Kg)
Table 16. Global Monoclonal Antibodies Sales Market Share by Region (2016-2021)
Table 17. Global Monoclonal Antibodies Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Monoclonal Antibodies Sales by Country (2016-2021) & (Kg)
Table 19. North America Monoclonal Antibodies Sales Market Share by Country (2016-2021)
Table 20. North America Monoclonal Antibodies Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Monoclonal Antibodies Revenue Market Share by Country (2016-2021)
Table 22. Europe Monoclonal Antibodies Sales by Country (2016-2021) & (Kg)
Table 23. Europe Monoclonal Antibodies Sales Market Share by Country (2016-2021)
Table 24. Europe Monoclonal Antibodies Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Monoclonal Antibodies Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Monoclonal Antibodies Sales by Region (2016-2021) & (Kg)
Table 27. Asia Pacific Monoclonal Antibodies Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Monoclonal Antibodies Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Monoclonal Antibodies Revenue Market Share by Region (2016-2021)
Table 30. Latin America Monoclonal Antibodies Sales by Country (2016-2021) & (Kg)
Table 31. Latin America Monoclonal Antibodies Sales Market Share by Country (2016-2021)
Table 32. Latin America Monoclonal Antibodies Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Monoclonal Antibodies Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Monoclonal Antibodies Sales by Country (2016-2021) & (Kg)
Table 35. Middle East and Africa Monoclonal Antibodies Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Monoclonal Antibodies Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Monoclonal Antibodies Revenue Market Share by Country (2016-2021)
Table 38. Global Monoclonal Antibodies Sales (Kg) by Type (2016-2021)
Table 39. Global Monoclonal Antibodies Sales Market Share by Type (2016-2021)
Table 40. Global Monoclonal Antibodies Revenue (Million US$) by Type (2016-2021)
Table 41. Global Monoclonal Antibodies Revenue Share by Type (2016-2021)
Table 42. Global Monoclonal Antibodies Price (USD/Kg) by Type (2016-2021)
Table 43. Global Monoclonal Antibodies Sales (Kg) by Application (2016-2021)
Table 44. Global Monoclonal Antibodies Sales Market Share by Application (2016-2021)
Table 45. Global Monoclonal Antibodies Revenue (Million US$) by Application (2016-2021)
Table 46. Global Monoclonal Antibodies Revenue Share by Application (2016-2021)
Table 47. Global Monoclonal Antibodies Price (USD/Kg) by Application (2016-2021)
Table 48. AbbVie Corporation Information
Table 49. AbbVie Description and Business Overview
Table 50. AbbVie Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 51. AbbVie Monoclonal Antibodies Product
Table 52. AbbVie Recent Developments/Updates
Table 53. Roche Corporation Information
Table 54. Roche Description and Business Overview
Table 55. Roche Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 56. Roche Monoclonal Antibodies Product
Table 57. Roche Recent Developments/Updates
Table 58. Johnson & Johnson Corporation Information
Table 59. Johnson & Johnson Description and Business Overview
Table 60. Johnson & Johnson Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 61. Johnson & Johnson Monoclonal Antibodies Product
Table 62. Johnson & Johnson Recent Developments/Updates
Table 63. Amgen Corporation Information
Table 64. Amgen Description and Business Overview
Table 65. Amgen Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 66. Amgen Monoclonal Antibodies Product
Table 67. Amgen Recent Developments/Updates
Table 68. Merck Corporation Information
Table 69. Merck Description and Business Overview
Table 70. Merck Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 71. Merck Monoclonal Antibodies Product
Table 72. Merck Recent Developments/Updates
Table 73. BMS Corporation Information
Table 74. BMS Description and Business Overview
Table 75. BMS Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 76. BMS Monoclonal Antibodies Product
Table 77. BMS Recent Developments/Updates
Table 78. Eli Lilly Corporation Information
Table 79. Eli Lilly Description and Business Overview
Table 80. Eli Lilly Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 81. Eli Lilly Monoclonal Antibodies Product
Table 82. Eli Lilly Recent Developments/Updates
Table 83. Formation Biologics Corporation Information
Table 84. Formation Biologics Description and Business Overview
Table 85. Formation Biologics Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 86. Formation Biologics Monoclonal Antibodies Product
Table 87. Formation Biologics Recent Developments/Updates
Table 88. Genmab Corporation Information
Table 89. Genmab Description and Business Overview
Table 90. Genmab Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 91. Genmab Monoclonal Antibodies Product
Table 92. Genmab Recent Developments/Updates
Table 93. GlaxoSmithKline Corporation Information
Table 94. GlaxoSmithKline Description and Business Overview
Table 95. GlaxoSmithKline Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 96. GlaxoSmithKline Monoclonal Antibodies Product
Table 97. GlaxoSmithKline Recent Developments/Updates
Table 98. Human Genome Sciences Corporation Information
Table 99. Human Genome Sciences Description and Business Overview
Table 100. Human Genome Sciences Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 101. Human Genome Sciences Monoclonal Antibodies Product
Table 102. Human Genome Sciences Recent Developments/Updates
Table 103. mmunogen Corporation Information
Table 104. mmunogen Description and Business Overview
Table 105. mmunogen Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 106. mmunogen Monoclonal Antibodies Product
Table 107. mmunogen Recent Developments/Updates
Table 108. MedImmune Corporation Information
Table 109. MedImmune Description and Business Overview
Table 110. MedImmune Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 111. MedImmune Monoclonal Antibodies Product
Table 112. MedImmune Recent Developments/Updates
Table 113. Novartis Corporation Information
Table 114. Novartis Description and Business Overview
Table 115. Novartis Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 116. Novartis Monoclonal Antibodies Product
Table 117. Novartis Recent Developments/Updates
Table 118. Pfizer Corporation Information
Table 119. Pfizer Description and Business Overview
Table 120. Pfizer Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 121. Pfizer Monoclonal Antibodies Product
Table 122. Pfizer Recent Developments/Updates
Table 123. Seattle Genetics Corporation Information
Table 124. Seattle Genetics Description and Business Overview
Table 125. Seattle Genetics Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 126. Seattle Genetics Monoclonal Antibodies Product
Table 127. Seattle Genetics Recent Developments/Updates
Table 128. Stemcentrx Corporation Information
Table 129. Stemcentrx Description and Business Overview
Table 130. Stemcentrx Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 131. Stemcentrx Monoclonal Antibodies Product
Table 132. Stemcentrx Recent Developments/Updates
Table 133. Synthon Biopharmaceuticals Corporation Information
Table 134. Synthon Biopharmaceuticals Description and Business Overview
Table 135. Synthon Biopharmaceuticals Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 136. Synthon Biopharmaceuticals Monoclonal Antibodies Product
Table 137. Synthon Biopharmaceuticals Recent Developments/Updates
Table 138. Takeda Corporation Information
Table 139. Takeda Description and Business Overview
Table 140. Takeda Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 141. Takeda Monoclonal Antibodies Product
Table 142. Takeda Recent Developments/Updates
Table 143. Teva Corporation Information
Table 144. Teva Description and Business Overview
Table 145. Teva Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 146. Teva Monoclonal Antibodies Product
Table 147. Teva Recent Developments/Updates
Table 148. Production Base and Market Concentration Rate of Raw Material
Table 149. Key Suppliers of Raw Materials
Table 150. Monoclonal Antibodies Distributors List
Table 151. Monoclonal Antibodies Customers List
Table 152. Monoclonal Antibodies Market Trends
Table 153. Monoclonal Antibodies Growth Drivers
Table 154. Monoclonal Antibodies Market Restraints
Table 155. Global Monoclonal Antibodies Sales Forecast by Type (2022-2027) & (Kg)
Table 156. Global Monoclonal Antibodies Sales Market Share Forecast by Type (2022-2027)
Table 157. Global Monoclonal Antibodies Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 158. Global Monoclonal Antibodies Revenue Market Share Forecast by Type (2022-2027)
Table 159. Global Monoclonal Antibodies Sales Forecast by Application (2022-2027) & (Kg)
Table 160. Global Monoclonal Antibodies Sales Market Share Forecast by Application (2022-2027)
Table 161. Global Monoclonal Antibodies Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 162. Global Monoclonal Antibodies Revenue Market Share Forecast by Application (2022-2027)
Table 163. Global Monoclonal Antibodies Sales Forecast by Region (2022-2027) & (Kg)
Table 164. Global Monoclonal Antibodies Sales Market Share Forecast by Region (2022-2027)
Table 165. Global Monoclonal Antibodies Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 166. Global Monoclonal Antibodies Revenue Market Share Forecast by Region (2022-2027)
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Monoclonal Antibodies
Figure 2. Global Monoclonal Antibodies Market Share by Type in 2020 & 2027
Figure 3. Cancer Product Picture
Figure 4. Autoimmune Diseases Product Picture
Figure 5. Infection Product Picture
Figure 6. Hematological Diseases Product Picture
Figure 7. Others Product Picture
Figure 8. Global Monoclonal Antibodies Market Share by Application in 2020 & 2027
Figure 9. Oncology
Figure 10. Autoimmune and inflammatory diseases
Figure 11. Respiratory diseases
Figure 12. Ophthalmology
Figure 13. Global Monoclonal Antibodies Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Monoclonal Antibodies Market Size 2016-2027 (US$ Million)
Figure 15. Global Monoclonal Antibodies Sales 2016-2027 (Kg)
Figure 16. Global Monoclonal Antibodies Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Monoclonal Antibodies Sales Share by Manufacturers in 2020
Figure 18. Global Monoclonal Antibodies Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Monoclonal Antibodies Players: Market Share by Revenue in 2020
Figure 20. Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Monoclonal Antibodies Sales Market Share by Region (2016-2021)
Figure 22. Global Monoclonal Antibodies Sales Market Share by Region in 2020
Figure 23. Global Monoclonal Antibodies Revenue Market Share by Region (2016-2021)
Figure 24. Global Monoclonal Antibodies Revenue Market Share by Region in 2020
Figure 25. U.S. Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Taiwan Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Philippines Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Vietnam Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. U.A.E Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Monoclonal Antibodies by Type (2016-2021)
Figure 50. Sales Market Share of Monoclonal Antibodies by Application (2016-2021)
Figure 51. Sales Market Share of Monoclonal Antibodies by Application in 2020
Figure 52. Revenue Share of Monoclonal Antibodies by Application (2016-2021)
Figure 53. Revenue Share of Monoclonal Antibodies by Application in 2020
Figure 54. Manufacturing Cost Structure of Monoclonal Antibodies
Figure 55. Manufacturing Process Analysis of Monoclonal Antibodies
Figure 56. Monoclonal Antibodies Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
  • Global Monoclonal Antibodies Market Growth 2021-2026
    Published: 22-Feb-2021        Price: US 3660 Onwards        Pages: 164
    According to this latest study, the 2020 growth of Monoclonal Antibodies will have significant change from previous year. By the most conservative estimates of global Monoclonal Antibodies market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Monoclonal Antibodies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This repor......
  • Global Monoclonal Antibodies Market Research Report 2021
    Published: 19-Feb-2021        Price: US 2900 Onwards        Pages: 123
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Cancer - Autoimmune Diseases - Infection - Hematological Diseases - Others Seg......
  • Global Anti-CD20 Monoclonal Antibodies Market Research Report 2021
    Published: 19-Feb-2021        Price: US 2900 Onwards        Pages: 119
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - First Generation Anti-CD20 Monoclonal Antibody - Second Generation Anti-CD20 Monoclonal Antibody - Third Ge......
  • Global Antibody Market Analysis 2016-2020 and Forecast 2021-2026
    Published: 06-Feb-2021        Price: US 2980 Onwards        Pages: 86
    Snapshot In Vitro Diagnostics (IVD) are tests used to detect disease, infections and other medical conditions. IVD antibodies are widely used for immunology methods such as immunonephelometry and sandwich ELISA. The global Antibody market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry enviro......
  • Global Antibody Market Research Report 2021
    Published: 04-Feb-2021        Price: US 2900 Onwards        Pages: 119
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - IgM - IgG - IgA - Other Segment by Application - Therapeutic - Research......
  • Global Antibody Market Growth 2021-2026
    Published: 04-Feb-2021        Price: US 3660 Onwards        Pages: 167
    According to this latest study, the 2020 growth of Antibody will have significant change from previous year. By the most conservative estimates of global Antibody market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 7989.2 million in 2019. Over the next five years the Antibody market will register a 5.5% CAGR in terms of revenue, the global market size will reach US$ 9896.5 million by 2025. This report presents a comprehensive ove......
  • Global Antibody Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
    Published: 26-Jan-2021        Price: US 3500 Onwards        Pages: 121
    Based on the Antibody market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail.......
  • Global Antibody Production Market Research Report 2021
    Published: 13-Jan-2021        Price: US 2900 Onwards        Pages: 92
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Polyclonal antibody - Monoclonal antibody - Murine - Chimeric - Humanized Segm......
  • Global Monoclonal Antibody Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
    Published: 12-Jan-2021        Price: US 3500 Onwards        Pages: 114
    A monoclonal antibody, abbreviated as a monoclonal antibody, is an antibody produced by only one type of immune cell, relative to a polyclonal antibody. A monoclonal antibody is produced by a cell in which an immune cell capable of producing such an antibody is fused with a cancer cell, and the fused cell has both the ability of the tumor cell to continuously divide and the ability of the immune cell to produce an antibody. The fused hybrid cells can produce a large number of identical antibodie......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs